New York Launches Into Medical Pot With No Buds In Sight

Follow TIS on Twitter: @Truth_is_Scary & Like TIS of Facebook- facebook.com/TruthisScary

HIGHTIMES 

In a sleek Manhattan storefront with an upscale-doctor’s-office ambience, New York’s measured foray into medical marijuana begins Thursday with a liquid packaged with a plain white label.

Behind an understated, secured entrance, pharmacists at New York City’s first medical marijuana dispensary will consult with patients whose doctors must take special training to recommend the drug, allowed only in forms that can’t be smoked. There’s not a marijuana leaf in sight.

It’s a far cry from dispensaries in such states as California, where jars of buds feature evocative names. New York, where eight dispensaries are set to open around the state Thursday, has some of the strictest rules among the more than 20 states that allow medical pot.

Patients and their advocates fear New York is putting up too many roadblocks, and it’s unclear how many patients, if any, will be ready to walk through dispensary doors Thursday. But operators say the state’s stringency will help convey professionalism as the industry matures.

“This is a medication. This is a serious opportunity to treat patients who haven’t necessarily found the treatment they need,” said Nicholas Vita, CEO of Columbia Care, the Manhattan dispensary’s operator. New York’s program “is going to be a game-changer for the industry … because nobody’s going to let anything slip through the cracks.”

Almost two decades after California became the first state to legalize medical marijuana, New York lawmakers agreed in June 2014 to a version that sought to balance patient demand with officials’ concerns that the drug could be diverted to recreational use.

New York is the only state besides Minnesota to limit medical marijuana to non-smokeable extracts delivered in forms such as capsules, vaporizers and liquids taken orally, and it’s one of few states with a physician training requirement. New York limited its program to 20 dispensaries and a short list of qualified conditions such as cancer, AIDS, multiple sclerosis and epilepsy.

As Thursday’s implementation date approached, the law’s advocates sounded alarms about patients’ ability to access the long-awaited drug.

Missy Miller, the mother of a 16-year-old with epilepsy that causes multiple seizures per day, lobbied for the law and looked forward to the day when her son could legally try a treatment other patients have reported finding helpful.

But that day won’t be Thursday. Her son’s physician is holding off on taking the required course, and she hasn’t been able to find another doctor who has.

Read More HERE